Unlocking the Double-Edged Sword of TGF-β to Harness the Therapeutic Potential for Immuno-Oncology

In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine...